KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Assets (2019 - 2025)

Historic Return on Assets for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.03%.

  • BioNTech SE's Return on Assets fell 300.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.03% for FY2024, which is 900.0% down from last year.
  • Per BioNTech SE's latest filing, its Return on Assets stood at 0.03% for Q3 2025, which was down 300.0% from 0.02% recorded in Q2 2025.
  • BioNTech SE's Return on Assets' 5-year high stood at 1.34% during Q4 2021, with a 5-year trough of 0.04% in Q1 2025.
  • Its 5-year average for Return on Assets is 0.46%, with a median of 0.26% in 2023.
  • Per our database at Business Quant, BioNTech SE's Return on Assets skyrocketed by 12900bps in 2021 and then plummeted by -8100bps in 2023.
  • BioNTech SE's Return on Assets (Quarter) stood at 1.34% in 2021, then tumbled by -59bps to 0.55% in 2022, then plummeted by -86bps to 0.08% in 2023, then plummeted by -140bps to 0.03% in 2024, then increased by 4bps to 0.03% in 2025.
  • Its Return on Assets stands at 0.03% for Q3 2025, versus 0.02% for Q2 2025 and 0.04% for Q1 2025.